Gossamer Bio, INC Form 4 insider transactions

Director Skye Drynan acquired 230,000 stock options in Gossamer Bio, Inc. on March 11, 2024, at an exercise price of $1.34.

Director Steven D. Nathan acquired 230,000 stock options in Gossamer Bio, Inc. on March 11, 2024.